CYTK FY 2021 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$70M+26.2% YoY

Gross Profit

-$90M-127.1% margin

Operating Income

-$186M-264.5% margin

Net Income

-$215M-305.7% margin

EPS (Diluted)

$-2.80

Cash Flow

Operating Cash Flow

-$143M

Free Cash Flow

-$191M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$841M

Total Liabilities

$597M

Stockholders' Equity

$244M

Cash & Equivalents

$113M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$70M	$56M	+26.2%
Gross Profit	-$90M	-$41M	-117.7%
Operating Income	-$186M	-$94M	-98.3%
Net Income	-$215M	-$127M	-69.2%